Journal of Cardiovascular Disease Research
Role Of Ramosetron 5-HT3 Receptor Antagonists In The Treatment Of Irritable Bowel Syndrome (Diarrhea Dominant)
Dr. Ashish Ranjan, Dr. Deepak Kumar, Dr. Chaman Jee
JCDR. 2020: 118-123
Abstract
Background: One of the most common functional gastrointestinal illnesses, irritable bowel syndrome (IBS), significantly impairs quality of life. The present study was conducted to assess the role of the 5-HT3 receptor antagonist Ramosetron in the treatment of irritable bowel syndrome.
» PDF